Crinetics Pharmaceuticals (CRNX) Earnings
|
Expand Research on CRNX
| Next EPS Date | 8/11/26 | EPS Growth Rate | +0.8% |
|---|---|---|---|
| Average EPS % Beat Rate | -3.6% | Revenue Growth Rate | +1,382.0% |
| Average % Move 1-Wk after EPS | -5.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$1.22 | N/A | N/A | $14.82M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$1.23 | -$1.28 | +$0.05 | $10.7M | $8.51M | N/A |  | | Details | |
| 2/26/26 | Q425 | -$1.29 | -$1.34 | +$0.05 | $6.1M | $4M | N/A | | | Details | |
| 11/6/25 | Q325 | -$1.38 | -$1.25 | -$0.13 | $143K | $491K | N/A | | | Details | |
| 8/7/25 | Q225 | -$1.23 | -$1.10 | -$0.13 | $1M | $750.11K | N/A | | | Details | |
| 5/8/25 | Q125 | -$1.04 | -$0.93 | -$0.11 | $360K | $137.5K | N/A | | | Details | |
| 2/27/25 | Q424 | -$0.88 | -$0.88 | $0.00 | N/A | $666.67K | N/A | | | Details | |
| 11/12/24 |
Q324 | N/A | -$0.91 | N/A | N/A | $218.09K | N/A | N/A | N/A |
